Sculptra™
Sculptra™ has been approved by the FDA
for use in the United States following several years of use in
other countries under the name NewFill. The current FDA
approval is for restoration of facial fat loss (lipoatrophy)
in patients with human immunodeficiency virus, however, the
off label use for cosmetic purposes is rapidly growing in
popularity. (This is similar to the use of Botox for cosmetic
purposes prior to FDA approval for wrinkles.) Until the
introduction of Scupltra, physicians in the United States have
wanted options for the restoration of facial volume loss.
Volume loss, or “deflation,” is typical of the aging face and
although modern facelifting techniques are highly effective,
their greatest shortcoming lies in the fact that they do not
restore lost volume. The cosmetic use of Scuptra appears to be
most appropriate for the patient who has had a facelift and
still has a thin, gaunt face and for the forty something
patient with early aging not yet ready for a facelift.
Facial fat loss, or lipoatrophy, is the loss of fat beneath
the skin, which can result in sunken cheeks, indentations, and
hollow eyes. Sculptra™ is a synthetic material that is
injected below the surface of the skin in the area of fat
loss. It is composed of tiny particles of a dissolving suture
material which has been used in surgery for many years with an
excellent record of safety. It provides a gradual and
significant increase in skin thickness and tone, improving the
appearance of folds and sunken areas. The number of treatment
sessions depends of the severity of the facial lipoatrophy or
“deflation,” the individual response to treatment and the
desires of the patient. No skin testing is required.
click on the photo to view closer look
35 year old woman
Disclaimer: This Dallas cosmetic surgery website is intended to provide general information regarding cosmetic surgery and to help you find a Dallas cosmetic surgeon. If you are looking for one of Dallas' best plastic surgeons contact us today. |
